A retrospective case series of 20 patients with immunotherapy-induced bullous pemphigoid with emphasis on management outcomes

J Am Acad Dermatol. 2022 Dec;87(6):1394-1395. doi: 10.1016/j.jaad.2022.08.001. Epub 2022 Aug 5.

¹ McGovern Medical School, The University of Texas Health Science Center at Houston, Houston, Texas.
² Department of Dermatology, The University of Texas MD Anderson Cancer Center, Houston, Texas; Department of Dermatology, University of Texas Health Science Center at Houston, Houston, Texas.
³ Department of Dermatology, The University of Texas MD Anderson Cancer Center, Houston, Texas.
⁴ Department of Dermatology, The University of Texas MD Anderson Cancer Center, Houston, Texas. Electronic address: MMcIntosh1@mdanderson.org.

No abstract available

MeSH terms